首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1522899

角膜移植市场规模、份额和成长分析：按适应症、类型、最终用户和地区 - 产业预测，2024-2031 年

Corneal Transplant Market Size, Share, Growth Analysis, By Indications, By Type, By End-user, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年角膜移植市场规模为4.558亿美元，从2023年的4.8999亿美元增加至2031年的8.7388亿美元，复合年增长率预计为7.5%。

美国国立卫生研究院 (NIH) 报告称，大约 10% 至 15% 的圆锥角膜患者可能需要角膜移植作为治疗方法的一部分。这凸显了角膜植入在控制和减少圆锥角膜影响方面的关键作用，而圆锥角膜影响了很大一部分人口。此外，角膜失明是一个重大的全球健康问题，是继青光眼和白内障之后的第三大失明原因，估计影响全球 1,000 万人。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Carl Zeiss Meditec AG（Germany）
Alcon, Inc.（Switzerland）
Bausch & Lomb Incorporated（United States）
Abbott Medical Optics, Inc.（United States）
CooperVision, Inc.（United States）
STAAR Surgical Company（United States）
Topcon Corporation（Japan）
Johnson & Johnson Vision Care, Inc.（United States）
Lumenis Ltd.（Israel）
NIDEK Co., Ltd.（Japan）
Haag-Streit AG（Switzerland）
Ziemer Ophthalmic Systems AG（Switzerland）
Essilor International SA（France）
Allergan, Inc.（Ireland）
HOYA Corporation（Japan）
Menicon Co., Ltd.（Japan）
Novartis AG（Switzerland）
SynergEyes, Inc.（United States）
Oculus, Inc.（United States）
ZEISS Group（Germany）

简介目录

Product Code: SQMIG35A2814

Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

According to a report from the National Institutes of Health (NIH), approximately 10-15% of patients diagnosed with keratoconus may require a corneal implant procedure as part of their treatment regimen. This highlights the critical role of corneal implants in managing and mitigating the effects of keratoconus, a condition that affects a significant portion of the population. Additionally, corneal blindness represents a significant global health issue, ranking as the third-leading cause of blindness after glaucoma and cataracts, impacting an estimated 10 million individuals worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segmental Analysis

The corneal transplant market is segmented based on indication, type, end user, and region. Based on indications, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others. Based on type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty, corneal graft, corneal limbal stem cell transplant, and others. Based on end-user, the market is segmented into hospitals, eye clinics, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Drivers of the Corneal Transplant Market

The corneal transplant market is experiencing substantial growth, driven primarily by the rising prevalence of conditions such as keratoconus, Fuchs dystrophy, keratitis, and cataracts, which often necessitate corneal transplantation as a crucial medical intervention. Data from the Eye Research Foundation in the US indicates a significant burden, with approximately 100,000 individuals affected by these conditions, including an estimated 50 to 200 individuals grappling with complex corneal diseases like keratoconus. This prevalence underscores the increasing demand for corneal implants, highlighting their essential role in treating various eye disorders.

Restraints in the Corneal Transplant Market

The corneal transplant market encounters notable obstacles due to the substantial expenses involved in treatment and a scarcity of donor tissue, which are significant constraints on its expansion. The costs associated with corneal transplantation, including pre-operative evaluations, surgical procedures, and post-operative management, impose a considerable financial burden on both patients and healthcare systems. This high cost can restrict accessibility, particularly in areas with limited healthcare infrastructure.

Market Trends of the Corneal Transplant Market

The remarkable expansion seen in the corneal transplant market stems from various factors contributing to heightened demand for these advanced treatments. One prevalent condition driving this growth is late-onset Fuchs endothelial corneal dystrophy, which predominantly affects individuals aged 40 and older, as reported in a March 2020 article in the journal Progress in Retina and Eye Research.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Start-up Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Global Corneal Transplant Market by Indication

Market Overview
Fungal corneal ulcer
Bullous keratopathy
Keratoconus
Keratitis
Corneal stromal dystrophies
Others

Global Corneal Transplant Market by Type

Market Overview
Penetrating keratoplasty
Endothelial keratoplasty
Descemet stripping automated endothelial keratoplasty (DSAEK)
Corneal graft
Corneal limbal stem cell transplant
Others

Global Corneal Transplant Market by End User

Market Overview
Hospitals
Eye clinics
Others

Global Corneal Transplant Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Carl Zeiss Meditec AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon, Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch & Lomb Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Medical Optics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperVision, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STAAR Surgical Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NIDEK Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haag-Streit AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ziemer Ophthalmic Systems AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essilor International S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan, Inc. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menicon Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynergEyes, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oculus, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEISS Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments